Nu102 - Pharma Quiz 2

Front 1

IV hydralazine may be given undiluted via direct IV push at rate of 10 mg/min

Back 1

Peripheral vasodilators

Front 2

All of these should be discontinued slowly to avoid paradoxical hypertensive effects

Back 2

Peripheral vasodilators

Front 3

Monitor HR and BP closely during administration to prevent sudden hypotension

Back 3

Peripheral vasodilators

Front 4

Monitor serum thiocyanate levels with prolonged IV infusion and in clients with impaired renal function

Back 4

Peripheral vasodilators

Front 5

Decreased hematocrit and hemoglobin, anemia, agranulocyctosis (rare)

Back 5

Peripheral vasodilators

Front 6

When administering sodium nitropursside, monitor client for signs and symptoms of thiocyanate toxicity

Back 6

Peripheral vasodilators

Front 7

_______ toxicity: profound hypotension, tinnitus, fatigue, pink skin color, metabolic acidosis, and loss of consciousness

Back 7

Thiocyanate toxicity

Front 8

Establish a large, stable IV site for infusions b/c they are irritating to tissue; administer the med w/ IV infusion pump

Back 8

Peripheral vasodilators

Front 9

If adverse response is noted (e.g. hypotension), decrease infusion and monitor client closely

Back 9

Peripheral vasodilators

Front 10

If sudden severe hypotension occurs, discontinue medication; maintain ABCs; establish IV site; contact prescriber and initiate emergency protocols as necessary

Back 10

Peripheral vasodilators

Front 11

Stop smoking and avoid alcohol intake as they might negate positive effects of the medication

Back 11

Peripheral vasodilators

Front 12

Change position slowly and avoid hot tubs and hot baths that might induce profound vasodilation and hypotension

Back 12

Peripheral vasodilators

Front 13

side effects: postural hypotension, vasovagal attacks

Back 13

Nicotinic acid (niacin, vitamin B3)

Front 14

flushing

Back 14

Nicotinic acid (niacin, vitamin B3)

Front 15

Administer medication as ordered to maximize absorption and minimize potential side effects

Back 15

Nicotinic acid (niacin, vitamin B3)

Front 16

Dose is variable depending on whether it is prescribed to reduce cholesterol levels or as a vitamin supplement; be aware of specific dosing levels

Back 16

Nicotinic acid (niacin, vitamin B3)

Front 17

Expect the side effect of flushing when administering the medication

Back 17

Nicotinic acid (niacin, vitamin B3)

Front 18

Evaluate client for food sources high in niacin (dairy, meats, tuna, and eggs) and assess dietary intake

Back 18

Nicotinic acid (niacin, vitamin B3)

Front 19

Review list of medications with the client and determine if there are any possible drug interactions

Back 19

Nicotinic acid (niacin, vitamin B3)

Front 20

Change position slowly to avoid sudden BP drop

Back 20

Nicotinic acid (niacin, vitamin B3)

Front 21

Avoid direct exposure to sunlight

Back 21

Nicotinic acid (niacin, vitamin B3)

Front 22

Flushing in face, neck and ears may occur within 2 hours after oral ingestion and immediately after IV dose and may last several hours

Back 22

Nicotinic acid (niacin, vitamin B3)

Front 23

Alcohol can increase flushing

Back 23

Nicotinic acid (niacin, vitamin B3)

Front 24

Do not self-medicate with additional sources

Back 24

Nicotinic acid (niacin, vitamin B3)

Front 25

Drug selection depends on prescriber preference and client tolerance

Back 25

Statins

Front 26

They are not recommended for use in clients younger than age 20 years

Back 26

Statins

Front 27

Administer the med at dinner time to coincide with body;s timing of cholesterol production

Back 27

Statins

Front 28

Monitor results of baseline and periodically drawn LFT (liver function tests)

Back 28

Statins

Front 29

Monitor lipid levels within 2 to 4 weeks after initiation of therapy

Back 29

Statins

Front 30

Arrange for consult, if needed, w/ dietitian about the need for low-fat diet

Back 30

Statins

Front 31

May be given without regard to food

Back 31

Statins

Front 32

Proper self-administration in order to promote biochemical activity

Back 32

Statins

Front 33

Lab monitoring is required to maintain compliance and assess client response

Back 33

Statins

Front 34

Report immediately to the prescriber any unexplained muscle pain, tenderness, yellowing of skin or eyes, or loss of appetite

Back 34

Statins

Front 35

Alcohol intake should be minimized or avoided

Back 35

Statins

Front 36

Women should use contraceptives while taking these

Back 36

Statins

Front 37

Colestipol tablets should not be crushed, chewed or cut; they should be taken with adequate fluids

Back 37

Bile acid sequestrants

Front 38

Powdered drug forms should be mixed at bedside to prevent overthickening and esophageal obstruction

Back 38

Bile acid sequestrants

Front 39

Cholestyramine powder contains phenylalanine, so don't use if client has phenylketonuria (PKU)

Back 39

Bile acid sequestrants

Front 40

Should be administered alone dur to potential for increased binding effects with other medications

Back 40

Bile acid sequestrants

Front 41

give other drugs 1 to 2 hours before or 4 to 6 hours after med admin

Back 41

Bile acid sequestrants

Front 42

The contest of one packet should be mixed with at least 120 to 180 mL of liquid; undissolved med is irritation to mucous membranes

Back 42

Bile acid sequestrants

Front 43

Significant food interactions: powered forms must be mixed in the appropriate food or fluid to maximize absorption and prevent obstruction

Back 43

Bile acid sequestrants

Front 44

These meds are not usually used as a first line therapy to treat elevated cholesterol levels b/c of poor client tolerance

Back 44

Bile acid sequestrants

Front 45

Vitamin deficiencies may require supplementation, if not discontinuation of the med, to restore normal levels

Back 45

Bile acid sequestrants

Front 46

Problems related to hemorrhoids and/or constipation may require intervention to proved client comfort

Back 46

Bile acid sequestrants

Front 47

If the client develops GI complaints, a lower dosage may be necessary in order to maintain client compliance with this drug regimen

Back 47

Bile acid sequestrants

Front 48

Serum cholesterol levels are reduced within 24 to 48 hours after initiation of therapy

Back 48

Bile acid sequestrants

Front 49

Long-term use of cholestyramine can increase bleeding tendency

Back 49

Bile acid sequestrants

Front 50

Increase high-bulk diet with adequate fluid intake

Back 50

Bile acid sequestrants

Front 51

Do not omit doses

Back 51

Bile acid sequestrants

Front 52

Report constipation immediately

Back 52

Bile acid sequestrants

Front 53

Eat small, frequent meals when experiencing heartburn, nausea, or loss of appetite with colesevelam (Welchol)

Back 53

Bile acid sequestrants

Front 54

Bolus dose of lidocaine may be given undiluted via IVP at a rate of 25 to 50 mg/min

Back 54

Class I-B Antidysrhythmics

Front 55

Severe degrees of SA, AV, and intraventricular heart block are contraindicated

Back 55

Class I-B Antidysrhythmics

Front 56

Assess electrolytes and correct hypokalemia before treating with these

Back 56

Class I-B Antidysrhythmics

Front 57

hypotension, bradycardia, heart block, cardiovascular collapse, and cardiac arrest

Back 57

Class I-B Antidysrhythmics

Front 58

Assess ECG for changes including prolonged PR interval, widened QRS, aggravation of dysrhythmias, and heart block

Back 58

Class I-B Antidysrhythmics

Front 59

Administer via infusion pump and observe rate carefully

Back 59

Class I-B Antidysrhythmics

Front 60

Auscultate breath sounds for crackles and monitor respiratory rate

Back 60

Class I-B Antidysrhythmics

Front 61

Hypersensitivity to amiodarone

Back 61

Class III (potassium channel blockers)

Front 62

Cardiogenic shock

Back 62

Class III (potassium channel blockers)

Front 63

Sever sinus bradycardia or severe degrees of heart block

Back 63

Class III (potassium channel blockers)

Front 64

Hepatic disease

Back 64

Class III (potassium channel blockers)

Front 65

Use cautiously in: Hasimoto's thyroiditis, goiter, hyperthyroidism or hypothyroidism, CHF, electrolyte imbalance, preexisting pulmonary disease, cardiac surgery, and sensitivity to iodine

Back 65

Class III (potassium channel blockers)

Front 66

Bradycardia effects are greater when used with verapamil, diltiazem, and beta-andrenergic blockers

Back 66

Class III (potassium channel blockers)

Front 67

Monitor client continually due to unusually long half-life of the medication (10 to 55 days)

Back 67

Class III (potassium channel blockers)

Front 68

Report adverse reactions promptly

Back 68

Class III (potassium channel blockers)

Front 69

Be alert to signs of pulmonary toxicity: dyspnea, fatigue, cough, pleuritic pain or fever

Back 69

Class III (potassium channel blockers)

Front 70

Auscultate breath sounds for adventitious sounds

Back 70

Class III (potassium channel blockers)

Front 71

Assess pulse daily and report a HR less than 60 bpm

Back 71

Class III (potassium channel blockers)

Front 72

Photophobia may be eased by wearing darkened glasses but some clients should avoid daylight entirely

Back 72

Class III (potassium channel blockers)

Front 73

Erythema and pruritus may develop when exposed to ultraviolet radiation; avoid sunlight, tanning beds, and sunlamps

Back 73

Class III (potassium channel blockers)

Front 74

Blue-gray skin pigmentation may slowly disappear after med is stopped; may take months to resolve

Back 74

Class III (potassium channel blockers)

Front 75

Wear protective clothing and a barrier-type sunblock to avoid sun exposure (zinc-oxide or titanium-oxide preparations)

Back 75

Class III (potassium channel blockers)

Front 76

isosorbide dinitrate (Dilatrate-SR, Isordil)

Back 76

Nitrates and Nitrites

Front 77

isosorbide (Imdur, ISMO, Monoket)

Back 77

Nitrates and Nitrites

Front 78

nitroglycerin SL (Nitrostat)

Back 78

Nitrates and Nitrites

Front 79

nitroglycerin SR (Nitrong, Nitro-Bid)

Back 79

Nitrates and Nitrites

Front 80

nitroglycerin topical (Nitrol)

Back 80

Nitrates and Nitrites

Front 81

nitroglycerin transdermal (Depoint, Transderm-Nitro)

Back 81

Nitrates and Nitrites

Front 82

atenolol (Tenormin)

Back 82

Beta Blockers

Front 83

sotalol (Betapace)

Back 83

Beta Blockers

Front 84

metoprolol (Lopressor, Toprol XL)

Back 84

Beta Blockers

Front 85

nadolol (Corgard)

Back 85

Beta Blockers

Front 86

propranolol (Inderal)

Back 86

Beta Blockers

Front 87

timolol (Blocadren)

Back 87

Beta Blockers

Front 88

amlodipine (Norvasc)

Back 88

Calcium Channel Blocker

Front 89

bepridil HCl (Vascor)

Back 89

Calcium Channel Blocker

Front 90

diltiazem (cardizem, Dilacor XR, Tiazac)

Back 90

Calcium Channel Blocker

Front 91

felodipine (Plendil)

Back 91

Calcium Channel Blocker

Front 92

isradipine (DynaCirc)

Back 92

Calcium Channel Blocker

Front 93

nicardipine HCl (Cardene, Cardene SR)

Back 93

Calcium Channel Blocker

Front 94

nifedipine (Procardia, Adalat)

Back 94

Calcium Channel Blocker

Front 95

nisoldipine (Sular, Nisocor)

Back 95

Calcium Channel Blocker

Front 96

verapamil Hcl (Calan, Isoptin, Verelan)

Back 96

Calcium Channel Blocker

Front 97

digoxin (Lanoxin, Lanoxicaps)

Back 97

Cardiac Glycosides

Front 98

digitoxin (Crystodigin)

Back 98

Cardiac Glycosides